The roll of Toll-like receptors in the antiphospholipid syndrome.
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis, recurrent fetal loss, and the presence of antiphospholipid antibodies (aPL). Recent data support the idea that the thrombotic activity in APS patients is attributed to enhanced cytokine release via activation of certain Toll-like receptors. To investigate these mechanisms more precisely, different experimental approaches were used to investigate this connection in detail. IgG fractions and/or monoclonal aPL, either generated from murine or human B cells were intensely used for stimulation experiments of monocytes, endothelial cells, or dendritic cells. All these stimuli induced an enhanced expression and secretion of cytokines, especially tumor necrosis factor (TNF)-alpha, caused by specific regulation or activation of Toll-like receptors. Using specific agonists or inhibitors could confirm the causal connection of these stimulatory effects. This review focuses on these recent developments, connecting the binding of aPL with the activity of Toll-like receptors, especially in monocytes, endothelial cells, and dendritic cells.
Hurst
Julia
J
Chefarzt Institut für Labormedizin (IFLM), Solothurner Spitäler AG, Kantonsspital Olten, Baslerstrasse 150, 4601, Olten, Switzerland.
Lorenz
Mareike
M
Prinz
Nadine
N
von Landenberg
Philipp
P
D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000502:physiology*; D016736:Antiphospholipid Syndrome / Q000503:physiopathology*; D003713:Dendritic Cells / Q000276:immunology; D042783:Endothelial Cells / Q000276:immunology; D006801:Humans; D051379:Mice; D009000:Monocytes / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D013927:Thrombosis / Q000503:physiopathology; D051193:Toll-Like Receptors / Q000502:physiology*
D017152:Antibodies, Antiphospholipid; D051193:Toll-Like Receptors